These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

500 related items for PubMed ID: 17229184

  • 1. Diagnosis and treatment of obsessive-compulsive disorder and related disorders.
    Dell'Osso B, Altamura AC, Mundo E, Marazziti D, Hollander E.
    Int J Clin Pract; 2007 Jan; 61(1):98-104. PubMed ID: 17229184
    [Abstract] [Full Text] [Related]

  • 2. Issues in the pharmacological treatment of obsessive-compulsive disorder.
    Math SB, Janardhan Reddy YC.
    Int J Clin Pract; 2007 Jul; 61(7):1188-97. PubMed ID: 17511795
    [Abstract] [Full Text] [Related]

  • 3. Combining Drug and Psychological Treatments for Obsessive- Compulsive Disorder: What is the Evidence, When and for Whom.
    Albert U, Di Salvo G, Solia F, Rosso G, Maina G.
    Curr Med Chem; 2018 Jul; 25(41):5632-5646. PubMed ID: 28707590
    [Abstract] [Full Text] [Related]

  • 4. [Diversity of obsessive-compulsive disorder and pharmacotherapy associated with obsessive-compulsive spectrum disorders].
    Nakamae T.
    Seishin Shinkeigaku Zasshi; 2011 Jul; 113(10):1016-25. PubMed ID: 22187889
    [Abstract] [Full Text] [Related]

  • 5. Transcutaneous electrical acupoint stimulation as an adjunct therapy for obsessive-compulsive disorder: A randomized controlled study.
    Feng B, Zhang ZJ, Zhu RM, Yuan GZ, Luo LY, McAlonan GM, Xu FZ, Chen J, Liu LY, Lv YY, Wong HK, Zhang Y, Zhu LX.
    J Psychiatr Res; 2016 Sep; 80():30-37. PubMed ID: 27281260
    [Abstract] [Full Text] [Related]

  • 6. Obsessive-Compulsive Disorders.
    Mathews C.
    Continuum (Minneap Minn); 2021 Dec 01; 27(6):1764-1784. PubMed ID: 34881735
    [Abstract] [Full Text] [Related]

  • 7. Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders guidelines for the treatment of adult obsessive-compulsive disorder. Part I: pharmacological treatment.
    de Oliveira MVS, de Barros PMF, de Mathis MA, Boavista R, Chacon P, Echevarria MAN, Ferrão YA, Vattimo EFQ, Lopes AC, Torres AR, Diniz JB, Fontenelle LF, Rosário MCD, Shavitt RG, Miguel EC, da Silva RMF, Costa DLDC.
    Braz J Psychiatry; 2023 May 11; 45(2):146-161. PubMed ID: 36749887
    [Abstract] [Full Text] [Related]

  • 8. A review of pharmacologic treatments for obsessive-compulsive disorder.
    Kaplan A, Hollander E.
    Psychiatr Serv; 2003 Aug 11; 54(8):1111-8. PubMed ID: 12883138
    [Abstract] [Full Text] [Related]

  • 9. A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy.
    Albert U, Marazziti D, Di Salvo G, Solia F, Rosso G, Maina G.
    Curr Med Chem; 2018 Aug 11; 25(41):5647-5661. PubMed ID: 29278206
    [Abstract] [Full Text] [Related]

  • 10. Obsessive-compulsive disorder.
    Bokor G, Anderson PD.
    J Pharm Pract; 2014 Apr 11; 27(2):116-30. PubMed ID: 24576790
    [Abstract] [Full Text] [Related]

  • 11. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.
    Simpson HB, Foa EB, Liebowitz MR, Ledley DR, Huppert JD, Cahill S, Vermes D, Schmidt AB, Hembree E, Franklin M, Campeas R, Hahn CG, Petkova E.
    Am J Psychiatry; 2008 May 11; 165(5):621-30. PubMed ID: 18316422
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder.
    Varigonda AL, Jakubovski E, Bloch MH.
    J Am Acad Child Adolesc Psychiatry; 2016 Oct 11; 55(10):851-859.e2. PubMed ID: 27663940
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Obsessive-compulsive disorder: unearthing a hidden problem.
    El-Sayegh S, Bea S, Agelopoulos A.
    Cleve Clin J Med; 2003 Oct 11; 70(10):824-5, 829-30, 832-3, passim. PubMed ID: 14621230
    [Abstract] [Full Text] [Related]

  • 16. Increased maintenance of obsessive-compulsive disorder remission after integrated serotonergic treatment and cognitive psychotherapy compared with medication alone.
    Biondi M, Picardi A.
    Psychother Psychosom; 2005 Oct 11; 74(2):123-8. PubMed ID: 15741763
    [Abstract] [Full Text] [Related]

  • 17. [Evidence-based pharmacotherapy and other somatic treatment approaches for obsessive-compulsive disorder: state of the art].
    Kordon A, Zurowski B, Wahl K, Hohagen F.
    Nervenarzt; 2011 Mar 11; 82(3):319-20, 322-4. PubMed ID: 21340636
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A qualitative analysis of nonresponse: management of treatment-refractory obsessive-compulsive disorder.
    Pallanti S, Hollander E, Goodman WK.
    J Clin Psychiatry; 2004 Mar 11; 65 Suppl 14():6-10. PubMed ID: 15554782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.